Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : APC-148,Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Venus Remedies
Deal Size : Undisclosed
Deal Type : Collaboration
AdjuTec, Venus Remedies initiate research collaboration to evaluate APC-148 against AMR
Details : Venus Remedies will test APC-148, a selective inhibitor targeting bacterial MBL enzymes, in combination with various antibiotics against multidrug-resistant bacterial strains.
Product Name : APC-148
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
March 26, 2025
Lead Product(s) : APC-148,Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Venus Remedies
Deal Size : Undisclosed
Deal Type : Collaboration